Related Experiment Videos
[The effect of D-penicillamine on the course of chronic polyarthritis]
Acta Medica Austriaca
|January 1, 1975
Abstract:
The report deals with 8 years of clinical experience with long-term application of D-penicillamine in rheumatoid arthritis. The mode of action of D-penicillamine is discussed. It seems most probable that the influence of D-penicillamine implies an inhibition of the immunreaction.
Insights
D-penicillamine shows promise for rheumatoid arthritis treatment over 8 years. This drug likely works by inhibiting immune reactions, offering a new therapeutic avenue.
Area of Science:
- Immunology
- Rheumatology
- Pharmacology
Context:
- Clinical experience with long-term D-penicillamine application in rheumatoid arthritis.
- Evaluation of D-penicillamine's therapeutic effects and mechanism of action.
Purpose:
- To report on 8 years of clinical experience with D-penicillamine in rheumatoid arthritis.
- To discuss the probable mechanism of action of D-penicillamine.
Summary:
- Long-term (8-year) clinical data on D-penicillamine for rheumatoid arthritis.
- D-penicillamine's mechanism of action is likely related to the inhibition of immune reactions.
- Clinical efficacy and safety profile of D-penicillamine in managing rheumatoid arthritis.
Impact:
- Provides insights into the long-term efficacy and safety of D-penicillamine.
- Suggests a key immunomodulatory role for D-penicillamine in rheumatoid arthritis treatment.
- Contributes to understanding drug mechanisms in autoimmune diseases.